Peña-González G, Martínez-Luna E, Toussaint-Caire S, Arenas R, Vega-Sánchez DC

Language: Spanish
References: 10
Page: 204-205
PDF size: 77.22 Kb.

Text Extraction

No abstract.

REFERENCES

1. Nowak M, Putynkowska A, Baranska-Rybak W et al., Cutaneouscryptococcosis: an underlying immunosuppressión? Clinicalmanifestations, pathogenesis, diagnostic examinations andtreatment, Postepy Dermatol Alergol 2020; 37(2):154-8.

2. Chayakulkeeree M y Perfect JR, Cryptococcosis, Infect Dis ClinNorth Am 2006; 20:507-44.

3. Arenas R, Micología médica ilustrada, 5ª ed., México, McGrawHill, 2014, pp. 261-9.

4. Singh N, Alexander BD, Lortholary O et al., Cryptococcus neoformansin organ transplant recipients: impact of calcineurininhibitoragents on mortality, J Infect Dis 2007, 195:756-64.

5. Noguchi H, Matsumoto T, Kimura U et al., Cutaneous cryptococcosis,Med Mycol J 2019; 60:101-7.

6. James WD, Berger TG y Elston DM, Cryptococcosis. En Andrew’sdiseases of the skin, Clinical Dermatology, 12ª ed., 2016,pp. 305-6.

7. Noguchi H, Hiruma M, Maruo K, Jono M, Myata K et al., Localizedcutaneous cryptococcosis: summary of reported cases inJapan, Med Mycol J 2016; 57: e35-9.

8. Latino GA, Gago E, Vidau P y Vivanco B, Cutaneous cryptococcosisin a patient on chronic haemodialysis, Nefrología 2012;32:697-8.

9. Pau M, Lallai C, Aste N y Atzori L, Primary cutaenous cryptococcosisin an immunocompetent host, Mycoses 2010; 53(3):256-8.

10. Gaviria-Morales E, Guidi M, Peterka T et al., Primary cutaneouscryptococcosis due to Cryptococcus neoformans in an immunocompetentehost treated with itraconazole and drainage:case report and review of the literature, Case Rept Dermatol2021; 13:89-97.